Read how an Advanced MS Champion used their specialist knowledge to positively impact Barry's care.

Pulls together national guidelines for multiple sclerosis care and services in England, Scotland, Wales and Northern Ireland. Includes details about the revised NICE clinical guidelines, multiple sclerosis in adults: management, published in June 2022.

MS is most often diagnosed between the ages of 20-40, when many people may be thinking of starting, or extending, their family. Having MS can raise questions to consider, these may include: whether MS will affect your fertility; what the risk of your children developing MS is; what effect medications taken before and during pregnancy may have; and for women, what effect the pregnancy itself may have on your MS.

Vumerity (diroximel fumarate) is a disease modifying drug licenced for relapsing remitting multiple sclerosis (MS).  It is taken as two tablets, twice a day.

DMDs are a group of treatments for people with relapsing MS which reduce the number and severity of any relapses you might experience.

We’re excited to share our new organisational strategy and brand identity – both designed with one clear focus: putting people with MS at the heart of everything we do.

The Expanded Disability Status Scale (EDSS) measures your current level of disability. Neurologists use it to benchmark and monitor progression in multiple sclerosis.

Stay in the know with the latest news, research and stories from the MS community. Find the information that matters to you, all in one place.

The Auto1-MS1 CAR-T therapy for MS trial was announced in London, having infused their first MS patient with her own genetically modified T-cells.